Well, like I said above, mainly prions. But I’m sure there’s something else I’m overlooking. In this scenario I’m imagining commercial availability means it could pretty much come from anyone and would most likely be mixed from multiple people due to low production volumes. Something bad seems to happen when you do things like that, imo. But I’m just an armchair pathologist.